UNSPSC 51162011: Ephedrine/guaifenesin/phenobarbital/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162011 Ephedrine/guaifenesin/phenobarbital/theophylline is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The four most recent opportunities soliciting under this code involve naloxone and drug deactivation systems, on-site pharmacy services, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products — none of which fall within the respiratory medication combinations that the code nominally describes. The mismatch suggests either persistent miscoding in state and local procurement systems or that the UNSPSC taxonomy entry itself has drifted from current purchasing practice. State and local buying offices issuing under this code span county health departments (Seminole County, Florida; Hall County, Georgia), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration). The code shows activity across at least three states (Florida, Georgia, Texas, Minnesota and Oregon through cooperative purchasing), though the geographic spread is limited to recent solicitations in the Southeast and upper Midwest.

The representative recent opportunities reveal a fragmented purchasing landscape with no single dominant buyer pattern. Seminole County, Florida issued an Invitation for Bid (IFB 60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to a county health facility. Hall County, Georgia released an RFQ/P (#47-010, due June 4, 2026) for on-site pharmacy services serving approximately 3,005 eligible individuals at a county health center in Gainesville. The Texas HHS Commission issued a Request for Information (RFI HHS0017013, posted April 3, 2026) to gather vendor capabilities for implementing a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers across participating state and local facilities in Minnesota and Oregon. The code shows little relevant recent activity aligned with its stated scope; vendors evaluating pursuit should verify coding accuracy with issuing bodies before committing resources.